Zobrazeno 1 - 3
of 3
pro vyhledávání: '"K D, Jacobson"'
Publikováno v:
Clinical therapeutics. 14(2)
In this single-blind study, 488 patients with acute bronchitis were randomly assigned to receive 400 mg of loracarbef twice daily or 500/125 mg of amoxicillin/clavulanate three times daily for seven days. Treatment efficacy was evaluated in 98 patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::aa87b315e984c48e11ee31e651b8fa16
https://pubmed.ncbi.nlm.nih.gov/1611641
https://pubmed.ncbi.nlm.nih.gov/1611641
Publikováno v:
Clinical therapeutics. 14(2)
In this single-blind study, 579 patients with chronic bronchitis were randomly assigned to receive 400 mg of loracarbef twice daily or 500/125 mg of amoxicillin/clavulanate thrice daily for seven days. Treatment efficacy was evaluated in 129 of the l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1db3d17b12da3d7bb2e8d65f3678426
https://pubmed.ncbi.nlm.nih.gov/1611645
https://pubmed.ncbi.nlm.nih.gov/1611645
Autor:
J M Bundy, E F Finnerty, W R Drucker, K D Jacobson, A Kumar, T G Kreindler, K Waxman, D W Folan, C B Hanna, D L Murray
Publikováno v:
Antimicrobial agents and chemotherapy. 32(6)
In two prospective, randomized multicenter double-blind studies with a dosage of either 250 mg given four times a day (study A) or 500 mg given two times a day (study B), the comparative efficacy and safety of cephalexin hydrochloride (LY061188; Keft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f06d4d8abf4ce479e859493e06a64df
https://pubmed.ncbi.nlm.nih.gov/3046484
https://pubmed.ncbi.nlm.nih.gov/3046484